HRP20161364T1 - Alfa-1-mikroglobulin za uporabu za liječenje bolesti povezanih s mitohondrijima - Google Patents
Alfa-1-mikroglobulin za uporabu za liječenje bolesti povezanih s mitohondrijima Download PDFInfo
- Publication number
- HRP20161364T1 HRP20161364T1 HRP20161364TT HRP20161364T HRP20161364T1 HR P20161364 T1 HRP20161364 T1 HR P20161364T1 HR P20161364T T HRP20161364T T HR P20161364TT HR P20161364 T HRP20161364 T HR P20161364T HR P20161364 T1 HRP20161364 T1 HR P20161364T1
- Authority
- HR
- Croatia
- Prior art keywords
- lack
- deficiency
- mitochondrial
- microglobulin
- alpha
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1722—Plasma globulins, lactoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Nutrition Science (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201270538 | 2012-09-05 | ||
| DKPA201270557 | 2012-09-12 | ||
| PCT/EP2013/068270 WO2014037390A1 (en) | 2012-09-05 | 2013-09-04 | Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases |
| EP13759995.7A EP2900254B1 (en) | 2012-09-05 | 2013-09-04 | Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20161364T1 true HRP20161364T1 (hr) | 2016-12-16 |
Family
ID=49162118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20161364TT HRP20161364T1 (hr) | 2012-09-05 | 2013-09-04 | Alfa-1-mikroglobulin za uporabu za liječenje bolesti povezanih s mitohondrijima |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US10226507B2 (forum.php) |
| EP (1) | EP2900254B1 (forum.php) |
| JP (2) | JP2015533790A (forum.php) |
| KR (1) | KR20150047510A (forum.php) |
| CN (1) | CN104661673A (forum.php) |
| AU (1) | AU2013311714C1 (forum.php) |
| BR (1) | BR112015003957A2 (forum.php) |
| CA (1) | CA2881321A1 (forum.php) |
| DK (1) | DK2900254T3 (forum.php) |
| EA (1) | EA028963B1 (forum.php) |
| ES (1) | ES2599034T3 (forum.php) |
| HR (1) | HRP20161364T1 (forum.php) |
| HU (1) | HUE030559T2 (forum.php) |
| IN (1) | IN2015DN00515A (forum.php) |
| MX (1) | MX357656B (forum.php) |
| NZ (1) | NZ629621A (forum.php) |
| PL (1) | PL2900254T3 (forum.php) |
| PT (1) | PT2900254T (forum.php) |
| SG (1) | SG11201500669SA (forum.php) |
| WO (1) | WO2014037390A1 (forum.php) |
| ZA (1) | ZA201500547B (forum.php) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016204360A (ja) * | 2015-02-25 | 2016-12-08 | エー１エム ファーマ エービーＡ１Ｍ Ｐｈａｒｍａ ＡＢ | 放射性核種療法における腎臓の保護に用いるためのアルファ−１−ミクログロブリン |
| CA3014850A1 (en) * | 2016-02-25 | 2017-08-31 | A1M Pharma Ab | Alpha-1-microglobulin for use in the protection of kidneys in connection with use of contrast media |
| CN108779157B (zh) * | 2016-03-18 | 2022-12-30 | 卫士医疗国际公司 | 新α-1-微球蛋白衍生蛋白及其应用 |
| GB2566516A (en) | 2017-09-15 | 2019-03-20 | Univ Oxford Innovation Ltd | Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria |
| CN109867717A (zh) * | 2019-04-01 | 2019-06-11 | 山西瑞亚力生物技术有限公司 | 一种血浆中α1微球蛋白的提取方法 |
| CN110452980B (zh) * | 2019-09-23 | 2023-07-28 | 武汉儿童医院 | 一种线粒体脑肌病诊断试剂盒及应用 |
| US20220362293A1 (en) * | 2019-09-25 | 2022-11-17 | Cytegen Corp. | Treatment of Mitochondrial Deficits and Age-Related Diseases Using Blood Products |
| CN115575646B (zh) * | 2022-11-21 | 2023-04-28 | 四川大学华西医院 | 一种代谢标志物组在制备预测癫痫发作的试剂盒中的用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1882331A (zh) * | 2003-11-26 | 2006-12-20 | 塞诺菲-安万特德国有限公司 | 作为心血管风险升高指示剂的肾小管性蛋白尿 |
| ES2599003T3 (es) * | 2007-02-12 | 2017-01-31 | A1M Pharma Ab | Diagnóstico y tratamiento de preeclampsia |
| HRP20160024T1 (hr) * | 2008-02-04 | 2016-02-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Metode i sastavi za lijeäśenje mitohondrijskih poremeä†aja |
| PT2638915T (pt) * | 2008-07-18 | 2017-01-10 | A1M Pharma Ab | Utilização médica da alfa 1-microglobulina antioxidante e eliminadora de radicais |
-
2013
- 2013-09-04 HR HRP20161364TT patent/HRP20161364T1/hr unknown
- 2013-09-04 CA CA2881321A patent/CA2881321A1/en not_active Abandoned
- 2013-09-04 NZ NZ629621A patent/NZ629621A/en not_active IP Right Cessation
- 2013-09-04 EA EA201590503A patent/EA028963B1/ru not_active IP Right Cessation
- 2013-09-04 BR BR112015003957A patent/BR112015003957A2/pt not_active Application Discontinuation
- 2013-09-04 KR KR1020157005748A patent/KR20150047510A/ko not_active Ceased
- 2013-09-04 ES ES13759995.7T patent/ES2599034T3/es active Active
- 2013-09-04 US US14/423,260 patent/US10226507B2/en not_active Expired - Fee Related
- 2013-09-04 WO PCT/EP2013/068270 patent/WO2014037390A1/en not_active Ceased
- 2013-09-04 AU AU2013311714A patent/AU2013311714C1/en not_active Ceased
- 2013-09-04 HU HUE13759995A patent/HUE030559T2/en unknown
- 2013-09-04 DK DK13759995.7T patent/DK2900254T3/en active
- 2013-09-04 JP JP2015530375A patent/JP2015533790A/ja active Pending
- 2013-09-04 IN IN515DEN2015 patent/IN2015DN00515A/en unknown
- 2013-09-04 SG SG11201500669SA patent/SG11201500669SA/en unknown
- 2013-09-04 EP EP13759995.7A patent/EP2900254B1/en not_active Not-in-force
- 2013-09-04 CN CN201380043567.0A patent/CN104661673A/zh active Pending
- 2013-09-04 PT PT137599957T patent/PT2900254T/pt unknown
- 2013-09-04 MX MX2015002604A patent/MX357656B/es active IP Right Grant
- 2013-09-04 PL PL13759995T patent/PL2900254T3/pl unknown
-
2015
- 2015-01-23 ZA ZA2015/00547A patent/ZA201500547B/en unknown
-
2018
- 2018-08-24 JP JP2018157394A patent/JP2018203756A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20150258171A1 (en) | 2015-09-17 |
| NZ629621A (en) | 2015-09-25 |
| CN104661673A (zh) | 2015-05-27 |
| BR112015003957A2 (pt) | 2017-08-08 |
| CA2881321A1 (en) | 2014-03-13 |
| PL2900254T3 (pl) | 2017-02-28 |
| MX2015002604A (es) | 2015-06-10 |
| SG11201500669SA (en) | 2015-02-27 |
| EP2900254B1 (en) | 2016-08-03 |
| DK2900254T3 (en) | 2016-08-29 |
| EA201590503A1 (ru) | 2015-06-30 |
| AU2013311714A1 (en) | 2015-03-12 |
| EP2900254A1 (en) | 2015-08-05 |
| HUE030559T2 (en) | 2017-05-29 |
| HK1210585A1 (en) | 2016-04-29 |
| IN2015DN00515A (forum.php) | 2015-06-26 |
| PT2900254T (pt) | 2016-10-18 |
| AU2013311714C1 (en) | 2018-01-25 |
| JP2018203756A (ja) | 2018-12-27 |
| AU2013311714B2 (en) | 2017-10-12 |
| ZA201500547B (en) | 2017-09-27 |
| JP2015533790A (ja) | 2015-11-26 |
| US10226507B2 (en) | 2019-03-12 |
| EA028963B1 (ru) | 2018-01-31 |
| ES2599034T3 (es) | 2017-01-31 |
| KR20150047510A (ko) | 2015-05-04 |
| WO2014037390A1 (en) | 2014-03-13 |
| MX357656B (es) | 2018-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20161364T1 (hr) | Alfa-1-mikroglobulin za uporabu za liječenje bolesti povezanih s mitohondrijima | |
| JP2015533790A5 (forum.php) | ||
| Anokhina et al. | Racah coefficients and extended HOMFLY polynomials for all 5-, 6-and 7-strand braids | |
| Heer et al. | Population, pensions, and endogenous economic growth | |
| BR112014032321A2 (pt) | composição polimerizável para material ótico, material ótico obtido a partir da mesma composição e lentes plásticas | |
| EP2906547A4 (en) | COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE HYDROTROP AND AT LEAST ONE ACTIVE SUBSTANCE | |
| EA201400686A1 (ru) | ПРИМЕНЕНИЕ СОЕДИНЕНИЙ ТИПА СТРОБИЛУРИНОВ ДЛЯ БОРЬБЫ С ФИТОПАТОГЕННЫМИ ГРИБАМИ, УСТОЙЧИВЫМИ К ИНГИБИТОРАМ Qo | |
| EP2601168A4 (en) | TREATMENT OF MITOCHONDRIAL DISEASES BY VITAMIN K | |
| PH12018500238A1 (en) | Curable photochromic compositions | |
| BR112014014334A2 (pt) | máquina de lavar louça | |
| MX2017004523A (es) | Composición de activo suavizante de tela. | |
| MX2019003397A (es) | Metodos para tratar trastornos mitocondriales y metabolicos. | |
| MA44492A (fr) | Compositions ophtalmiques comprenant une cyclodextrine en tant qu'agent actif unique | |
| EP2538946A4 (en) | ANTIVIRAL FORMULATIONS | |
| Jerome et al. | Regulation of mitochondrial function by forkhead transcription factors | |
| BR112015014367A2 (pt) | formulações inibidoras de lfa-1 | |
| BR112017023264A2 (pt) | composição | |
| UY35668A (es) | Derivados de azabencimidazol como agonistas de ampk y composiciones farmacéuticas que los contienen | |
| BR112022010546A2 (pt) | Disco transversal de uma espiral de centrifugação e centrífuga em espiral de camisa sólida | |
| IN2015DN00890A (forum.php) | ||
| BR112014027301A8 (pt) | Suplemento alimentício de animal de estimação compreendendo um ingrediente sensível | |
| EP3937896C0 (en) | SUNSCREEN COMPOSITIONS COMPRISING BUTYL METHOXYDIBENZOYLEMETHANE, TRIAZINE DERIVATIVES AND A LIGHT STABILIZER | |
| PL419827A1 (pl) | Rozpórki do ram wylotowych systemów turbin | |
| MA34500B1 (fr) | Nouvelle composition pesticide | |
| BR112017022951A2 (pt) | microrganismos com capacidade fotossintética aumentada |